Swiss Hemophilia Registry

Hemophilia and Other Severe Bleeding Disorders Clinical Trial

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02512250
• Other study ID #: 2014-0667
• Status: Recruiting
• Start date: May 2015
• Est. completion date: December 2025

Study information

• Verified date: October 2022
• Source: Swiss Hemophilia Network
• Contact: Manuela Albisetti, MD
• Phone: +41 44 266 71 38
• Email: manuela.albisetti[@]kispi.uzh.ch
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

The Swiss Hemophilia Registry will collect data on the prophylactic and therapeutic use of factor concentrates in patients with hemophilia and other severe bleeding disorders in Switzerland.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 900
• Est. completion date: December 2025
• Est. primary completion date: December 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

Diagnosis of hemophilia or other severe bleeding disorders. Signed inform consent

Exclusion Criteria:

None

Related Conditions & MeSH terms

• Blood Coagulation Disorders
• Hemophilia A
• Hemophilia and Other Severe Bleeding Disorders
• Hemostatic Disorders

Intervention

Other:
• Registry

Locations

Country	Name	City	State
Switzerland	Kantonsspital Aarau Zentrum für Onkologie/Hämatologie und Transfusionsmedizin	Aarau
Switzerland	Kinderklinik	Aarau
Switzerland	Universitätskinderspital beider Basel (UKBB) Abteilung Onkologie/Hämatologie	Basel
Switzerland	Universitätsspital Basel Diagnostische Hämatologie	Basel
Switzerland	Ospedale San Giovanni	Bellinzona
Switzerland	Servizio di Ematologia Ospedale Regionale di Bellinzona e Valli	Bellinzona
Switzerland	Inselspital, Universitätsspital Bern Poliklinik für Hämatologie	Bern
Switzerland	Kantonspital Graubünden	Chur
Switzerland	Unité d'Hémostase HUG	Genève
Switzerland	Unité d'Oncologie-Hématologie pédiatrique, Hôpital des Enfants HUG	Genève
Switzerland	Centre Hospitalier Universitaire Vaudois Service d'Hématologie	Lausanne
Switzerland	Policlinique d'onco-hématologie péd., CHUV	Lausanne
Switzerland	Kantonsspital Luzern Abteilung Hämatologie	Luzern
Switzerland	Kinderspital Luzern	Luzern
Switzerland	Kinder und Erwachsenenzentrum Sion Service Régional Valaisan de Transfusion Sanguine CRS	Sion
Switzerland	Kantonspital St. Gallen	St. Gallen
Switzerland	Ostschweizer Kinderspital St. Gallen	St. Gallen
Switzerland	University Children's Hospital	Zürich
Switzerland	University Hospital Zürich	Zürich

Sponsors (1)

Lead Sponsor	Collaborator
Swiss Hemophilia Network

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of incidence of disease and inhibitor development	Demographics, Comorbidties, factor consumption for prophylaxis, bleeding and surgery, inhibito develeopment	1 year